The Medicines' CEO Presents At Deutsche Bank Annual Healthcare Conference (Transcript)

The Medicines Company (MDCO)

Deutsche Bank Annual Healthcare Conference Call

May 7, 2012 2:10 pm ET


Clive A. Meanwell – Chairman and Chief Executive Officer

William B. O’Connor – Vice President and Chief Accounting Officer


Navdeep Singh – Deutsche Bank Securities, Inc.


Navdeep Singh – Deutsche Bank Securities, Inc.

All right. Good afternoon, everyone, and thanks for joining us in for afternoon session. My name is Navdeep Singh, and I am one of the Biotech Analyst at Deutsche Bank. And it’s my pleasure to announce our next company The Medicines Company. And presenting on behalf of The Medicines Company is Clive Meanwell, Chairman and CEO. We also have Bill O’Connor, the Chief Accounting Officer on the stage today.

And before, we start our presentation I just want to give you guys a heads up. We have this new app that we trying out, we call the [Yorn] app. The instructions to use it are on your desks. And it’s just basically, if you don’t want to ask live question, and you want me to ask it on your behalf, feel free to follow the instructions then I will ask the question on your behalf.

So with that, Clive, you want to take the podium?

Clive A. Meanwell

Thank you very much, Navdeep, and thank you to Deutsche Bank for the invitation to this conference. I was worried that [Yorn] app meant that you had to push a button and there was trap door in the stage, but hopefully, no.

If you liked this article you might like

Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)

Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More

AveXis, Esperion and Amgen Among Biotech Movers